1. Home
  2. LZB vs ATAI Comparison

LZB vs ATAI Comparison

Compare LZB & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$35.97

Market Cap

1.3B

ML Signal

HOLD

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$4.97

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZB
ATAI
Founded
1927
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
LZB
ATAI
Price
$35.97
$4.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$42.50
$15.75
AVG Volume (30 Days)
328.7K
4.0M
Earning Date
02-17-2026
05-06-2026
Dividend Yield
2.70%
N/A
EPS Growth
N/A
N/A
EPS
1.65
N/A
Revenue
$2,349,433,000.00
$4,089,000.00
Revenue This Year
$1.89
N/A
Revenue Next Year
$2.09
N/A
P/E Ratio
$21.75
N/A
Revenue Growth
N/A
1227.60
52 Week Low
$29.03
$1.29
52 Week High
$44.49
$6.73

Technical Indicators

Market Signals
Indicator
LZB
ATAI
Relative Strength Index (RSI) 66.98 76.83
Support Level $35.32 $4.96
Resistance Level $39.71 $5.34
Average True Range (ATR) 0.83 0.25
MACD 0.52 0.11
Stochastic Oscillator 91.47 73.54

Price Performance

Historical Comparison
LZB
ATAI

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Share on Social Networks: